Form 8-K - Current report:
SEC Accession No. 0000950170-24-134765
Filing Date
2024-12-10
Accepted
2024-12-10 08:00:08
Documents
11
Period of Report
2024-12-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K stro-20241210.htm   iXBRL 8-K 45568
  Complete submission text file 0000950170-24-134765.txt   158581

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20241210.xsd EX-101.SCH 25165
13 EXTRACTED XBRL INSTANCE DOCUMENT stro-20241210_htm.xml XML 4527
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 241537152
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)